 BioReference Laboratories, Inc., an OPKO Health company NASDAQ: OPK, is now accepting specimens for testing of coronavirus disease 2019 COVID-19 from healthcare providers, clinics and health systems throughout the United States. In addition, BioReference has announced a partnership with the New York 